Topic: Pharmaceuticals

POSTS
VIDEO
NEWS

Ranbaxy will probably accept Daiichi Sankyo's buyout offer, predicts Aadil Ebrahim, investment manager at Bowen Capital Management. He revie...

Follow the Money

A bright spot in the beaten down pharma sector, with CNBC's Mike Huckman

Fresenius CEO on APP Deal

Germany's Fresenius plans to buy America's group APP Pharmaceuticals for $3.7 billion. Ulf Schneider, CEO of Fresenius, spoke to CNBC about ...

Biopharma Stocks on the Move

An update on the sector, with CNBC's Mike Huckman

Stent Wars Escalate

The FDA approves a new Abbott drug-coated stent, reports CNBC's Mike Huckman

Get on the Profit Bus

Transport stocks could benefit from the rocketing fuel costs, Andy Brough from Schroders told CNBC Tuesday.

Pharma's Future

Playing politics with healthcare, with Myrtle Potter, Genentech former president and COO

Cure for Merck's Migraine?

There could be news to help cure the headache being suffered by Merck investors, reports CNBC's Mike Huckman

Since the Last Fed Meeting

A look at what has happened to the U.S. economy and the market since the last Fed decision.

Posts | TOPIC : Pharmaceuticals

Cowen's "Elan" For Elan

Posted By:Mike Huckman | Pharmas Market with Mike Huckman

At the risk of being ganged up on by the "Elanians" who will take umbrage with the fact that the biopharma team at Cowen and Company is not initiating coverage of the Irish drugmaker with a "screaming buy," I am blogging about the analysts' 50-page call on the stock today... Read More

7 Jul 2008

UBS And Its Guarded Outlook For Merck's Gardasil

Posted By:Mike Huckman | Pharmas Market with Mike Huckman

Shares of Merck, which have lost more than a third of their value so far this year, are under continued pressure this morning... Read More

3 Jul 2008

Readers Get Short With Me--Over Amgen

Posted By:Mike Huckman | Pharmas Market with Mike Huckman

Ahead of the long holiday weekend I thought this would be as good a time as any to once again go through the "Pharma's Market" mailbag... Read More

2 Jul 2008

Biopharma Analyst Musical Chairs

Posted By:Mike Huckman | Pharmas Market with Mike Huckman

In the world of nearly 400 publicly-traded biotechs, analyst coverage is especially important... Read More

1 Jul 2008

Abbott, Boston Scientific Stents & Stuff

Posted By:Mike Huckman | Pharmas Market with Mike Huckman

So, I can now safely say, with complete confidence, that Food and Drug Administration approval of the new Abbott drug-coated stent will not happen in the second quarter... Read More

News | TOPIC : Pharmaceuticals

Elderly Are Getting More Love: Study

Source: CNBC.com

Eli Lilly to Buy SGX Pharmaceuticals for $64 Million

Source: The Associated Press

Abbott wins OK for drug-coated heart stent

Wednesday, 2 Jul 2008

Source: Reuters

Merck's Gardasil Vaccine Not Approved for Expansion

Wednesday, 25 Jun 2008

Source: Reuters

Walgreen Profit Up 2%, Helped By Cost Cutting